Cite

    Mu, X. et al. (n.d.). Famitinib enhances nasopharyngeal cancer cell radiosensitivity by attenuating radiation-induced phosphorylation of platelet-derived growth factor receptor and c-kit and inhibiting microvessel formation. International journal of radiation biology. pp. 771-776. [Online].